Sagard Capital's $170M Buy To Take IntegraMed Private

Law360, New York (June 11, 2012, 3:21 PM EDT) -- IntegraMed America Inc., the manager of outpatient specialty care facilities, plans to go private in a $169.5 million deal with private equity firm and IntegraMed shareholder Sagard Capital Partners LP, IntegraMed said Monday.

The $14.05-per-share cash offer represents a 24 percent premium over IntegraMed's Friday close, and a 46 percent premium on the company's average closing price over the past year. The deal is not subject to financing, according to IntegraMed.

Pending shareholder and regulatory approval, the transaction is expected to close by the end of...
To view the full article, register now.